H.R.5382

            

116th CONGRESS
1st Session
H. R. 5382

To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net
			 prices.
IN THE HOUSE OF REPRESENTATIVES
December 10, 2019
Mr.  Fortenberry introduced the following bill; which was referred to the Committee on Energy and Commerce
A BILL
To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net
			 prices.
 Be it enacted by the Senate and House of Representatives of the
		United States of America in Congress assembled,  The U.S. Government shall create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.